SCHEMBL17043093

SCHEMBL17043093

O=C(CCCC/C=C(\COc1cccc2ccccc12)C(=O)NCC1CCCO1)NOC1CCCCO1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ POLB P06746 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ LMNA P02545 4/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ ADAMTS4 O75173 1/20 0.38
▸ ADAMTS5 Q9UNA0 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17043096 1.00 P2RX3 (0.48) P2RX3ALDH1A1KDM4EPOLBHTT
SCHEMBL3847824 0.89 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBHTTHPGD
SCHEMBL3847829 0.89 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBHTTHPGD
SCHEMBL1306630 0.88 P2RX3 (0.49) P2RX3ALDH1A1KDM4EHPGDTSHR
SCHEMBL1306633 0.88 P2RX3 (0.49) P2RX3ALDH1A1KDM4EHPGDTSHR
SCHEMBL1307169 0.87 P2RX3 (0.55) P2RX3ALDH1A1KDM4EHTTHPGD
SCHEMBL1307168 0.87 P2RX3 (0.55) P2RX3ALDH1A1KDM4EHTTHPGD
SCHEMBL1306690 0.86 P2RX3 (0.47) P2RX3ALDH1A1KDM4EPOLBHTT
SCHEMBL3833477 0.86 P2RX3 (0.47) P2RX3ALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL1306688 0.86 P2RX3 (0.47) P2RX3ALDH1A1KDM4EPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2913322-A2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same Korea Research Institute Of Chemical Technology (KR) 2015-09-02 — — EP disclosed
Send feedback